What is Nanomedic Technologies?
Founded in 2018 and headquartered in Lod, Israel, Nanomedic Technologies is a pioneering medical therapeutics firm dedicated to the modernization of wound care. The company distinguishes itself through the development and distribution of its proprietary Electrospinning Healing Fiber (EHF) technology. Its flagship innovation, the Spincare System, represents a breakthrough in the field as the first CE-cleared, portable electrospinning device designed for commercial use. By providing a sterile, protective layer that mimics human skin, the Spincare System offers a sophisticated alternative to conventional dressings, effectively bridging the gap between hospital-grade treatment and outpatient care.
How much funding has Nanomedic Technologies raised?
Nanomedic Technologies has raised a total of $7M across 1 funding round:
Other Financing Round
$7M
Other Financing Round (2019): $7M, investors not publicly disclosed
Key Investors in Nanomedic Technologies
Undisclosed Investor
An undisclosed institutional investor providing strategic capital to support the commercialization of advanced medical device technologies.
Undisclosed Investor
A venture capital firm specializing in early-stage biotech and medical device innovation with a focus on disruptive healthcare solutions.
Undisclosed Investor
A specialized investment group focused on scaling therapeutic technologies that improve patient outcomes across the healthcare continuum.
What's next for Nanomedic Technologies?
With the recent influx of capital, Nanomedic Technologies is entering a phase of aggressive commercial scaling and operational maturation. The strategic roadmap focuses on the widespread adoption of the Spincare System, targeting both domestic and international healthcare markets. Future growth initiatives will likely prioritize the optimization of supply chain logistics and the expansion of clinical distribution networks to ensure the Spincare System becomes the new standard of care. As the company navigates this enterprise-level growth, it remains committed to rigorous research and development, aiming to refine its electrospinning platform to address a wider array of complex wound healing challenges. This phase of development is critical for establishing long-term sustainability and cementing the company's reputation as a leader in medical technology innovation.
See full Nanomedic Technologies company page
